Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Bacillus Subtilis1件: Bacillus subtilis (Bacillus subtilis)---3件: 6, 28, 96 💬
2Bacillus subtilis Capsules1件: Bacillus subtilis (Bacillus subtilis)---1件: 96 💬
3Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab5件: Bacillus subtilis (Bacillus subtilis),
Bortezomib,
Daratumumab,
Dexamethasone,
Enterococcus faecium		5件: Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬 		3件: CD38,
NR3C1,
PSMB5 💬 		15件: Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬1件: 28 💬